University of Tehran-, Tehran (Iran (Islamic Republic of))
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (EMPOAF), a randomized, double-blind, placebo-controlled trial
